These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33077648)

  • 1. Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an
    Kebriaei R; Lev KL; Stamper KC; Lehman SM; Morales S; Rybak MJ
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus.
    Kebriaei R; Lev K; Morrisette T; Stamper KC; Abdul-Mutakabbir JC; Lehman SM; Morales S; Rybak MJ
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant
    Save J; Que YA; Entenza J; Resch G
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant
    Indiani C; Sauve K; Raz A; Abdelhady W; Xiong YQ; Cassino C; Bayer AS; Schuch R
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of Bicarbonate Supplementation To Sensitize Selected Methicillin-Resistant
    Rose WE; Bienvenida AM; Xiong YQ; Chambers HF; Bayer AS; Ersoy SC
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness of Bacteriophages against Methicillin-Resistant Staphylococcus aureus ST398 Nasal Colonization in Pigs.
    Verstappen KM; Tulinski P; Duim B; Fluit AC; Carney J; van Nes A; Wagenaar JA
    PLoS One; 2016; 11(8):e0160242. PubMed ID: 27487020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant
    Lehman SM; Mearns G; Rankin D; Cole RA; Smrekar F; Branston SD; Morales S
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30669652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Phage-Derived Antimicrobial Agent HY-133 Is Active against Livestock-Associated Methicillin-Resistant Staphylococcus aureus.
    Kaspar U; de Haro Sautto JA; Molinaro S; Peters G; Idelevich EA; Becker K
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of
    Kebriaei R; Rice SA; Stamper KC; Rybak MJ
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could bacteriophages isolated from the sewage be the solution to methicillin-resistant Staphylococcus aureus?
    Tan CS; Aqiludeen NA; Tan R; Gowbei A; Mijen AB; Santhana Raj L; Ibrahim SF
    Med J Malaysia; 2020 Mar; 75(2):110-116. PubMed ID: 32281590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage Therapy for
    Plumet L; Ahmad-Mansour N; Dunyach-Remy C; Kissa K; Sotto A; Lavigne JP; Costechareyre D; Molle V
    Front Cell Infect Microbiol; 2022; 12():907314. PubMed ID: 35782148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Identification of a novel lytic bacteriophage obtained from clinical MRSA isolates and evaluation of its antibacterial activity].
    Sahin F; Karasartova D; Ozsan TM; Gerçeker D; Kıyan M
    Mikrobiyol Bul; 2013 Jan; 47(1):27-34. PubMed ID: 23390900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citral, a monoterpenoid aldehyde interacts synergistically with norfloxacin against methicillin resistant Staphylococcus aureus.
    Gupta P; Patel DK; Gupta VK; Pal A; Tandon S; Darokar MP
    Phytomedicine; 2017 Oct; 34():85-96. PubMed ID: 28899514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Field trial for eradication of methicillin- resistant Staphylococcus aureus (MRSA) in a pig breeding farm by bacteriophages].
    Honegger J; Lehnherr H; Bachofen C; Stephan R; Sidler X
    Schweiz Arch Tierheilkd; 2020 May; 162(5):307-317. PubMed ID: 32369023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    Yoneda A; Thänert R; Burnham CD; Dantas G
    Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage therapy in implant-related infections: an experimental study.
    Yilmaz C; Colak M; Yilmaz BC; Ersoz G; Kutateladze M; Gozlugol M
    J Bone Joint Surg Am; 2013 Jan; 95(2):117-25. PubMed ID: 23324958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.